Laurie Martin

Dr. Baker, director of the American Lyme Disease Foundation, who was responsible for overseeing The National Institute of Allergy and Infectious Diseases’ (NIAID) Lyme disease program, wrote in his article, “The results of 5 placebo-controlled clinical trials on the efficacy of extended antibiotic therapy for the treatment of post-Lyme disease symptoms provided no evidence of

The authors compared 16 individuals with Lyme disease receiving TNF-α inhibitors with 32 healthy controls to understand whether suppressing their immunity is harmful. The individuals had confirmed Lyme disease with an erythema migrans rash manifestation. The patients received immune-suppressing medications, which included adalimumab, infliximab, etanercept, golimumab. These were often combined with other immunosuppressant drugs for

Clinicians face great challenges in diagnosing disorders that involve symptoms seen in both general medicine and psychiatry, ” wrote Robert Bransfield, MD, a psychiatrist and professor at Rutgers Robert Wood Johnson Medical School. All too often, these patients are labeled as having “excessive” symptoms and given outdated diagnoses (i.e. psychosomatic disorder). Symptoms of Lyme disease

In their article “Functional signs in patients consulting for presumed Lyme borreliosis,” Voitey et al. [1] found that in the 48 patients diagnosed with Lyme disease, the most common functional symptoms were arthralgia (23%), neuropathic pain (23%) and asthenia (17%). Asthenia is characterized by abnormal physical weakness or lack of energy. Their result raise concerns whether